- Home
- MAIA vs LRFC Comparison
MAIA vs LRFC Comparison
Compare MAIA & LRFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- LRFC
- Stock Information
- Founded
- MAIA 2018
- LRFC 2013
- Country
- MAIA United States
- LRFC United States
- Employees
- MAIA N/A
- LRFC N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- LRFC Finance: Consumer Services
- Sector
- MAIA Health Care
- LRFC Finance
- Exchange
- MAIA Nasdaq
- LRFC Nasdaq
- Market Cap
- MAIA 46.7M
- LRFC 47.7M
- IPO Year
- MAIA 2022
- LRFC 2013
- Fundamental
- Price
- MAIA $2.03
- LRFC $17.70
- Analyst Decision
- MAIA
- LRFC
- Analyst Count
- MAIA 0
- LRFC 0
- Target Price
- MAIA N/A
- LRFC N/A
- AVG Volume (30 Days)
- MAIA 319.8K
- LRFC 14.0K
- Earning Date
- MAIA 05-20-2025
- LRFC 05-08-2025
- Dividend Yield
- MAIA N/A
- LRFC 8.00%
- EPS Growth
- MAIA N/A
- LRFC N/A
- EPS
- MAIA N/A
- LRFC N/A
- Revenue
- MAIA N/A
- LRFC $20,916,000.00
- Revenue This Year
- MAIA N/A
- LRFC N/A
- Revenue Next Year
- MAIA N/A
- LRFC N/A
- P/E Ratio
- MAIA N/A
- LRFC N/A
- Revenue Growth
- MAIA N/A
- LRFC 3.66
- 52 Week Low
- MAIA $1.40
- LRFC $17.30
- 52 Week High
- MAIA $5.99
- LRFC $26.00
- Technical
- Relative Strength Index (RSI)
- MAIA 53.91
- LRFC 24.53
- Support Level
- MAIA $1.80
- LRFC $17.68
- Resistance Level
- MAIA $2.18
- LRFC $18.24
- Average True Range (ATR)
- MAIA 0.30
- LRFC 0.36
- MACD
- MAIA -0.01
- LRFC 0.15
- Stochastic Oscillator
- MAIA 30.29
- LRFC 0.74
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.